Stock Research: DarioHealth

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

DarioHealth

NasdaqCM:DRIO US23725P2092
29
  • Value
    47
  • Growth
    69
  • Safety
    Safety
    65
  • Combined
    35
  • Sentiment
    8
  • 360° View
    360° View
    29
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

DarioHealth Corp. is a global digital therapeutics company delivering personalized, data-driven interventions. It operates in digital health, offering solutions for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health, and sells products like the Dario Blood Glucose Monitoring Starter Kit and Dario Blood Pressure Monitoring System. In the last fiscal year, the company had a market cap of $31 million, profits of $13 million, and revenue of $27 million, with 196 employees.

more
Index
NASDAQ
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
47 76 53 47
Growth
69 32 29 45
Safety
Safety
65 65 65 58
Sentiment
8 14 35 69
360° View
360° View
29 29 32 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
76 70 77 63
Opinions Change
50 23 50 50
Pro Holdings
n/a 4 18 18
Market Pulse
1 49 34 90
Sentiment
8 14 35 69
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
47 76 53 47
Growth
69 32 29 45
Safety Safety
65 65 65 58
Combined
35 35 41 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
34 34 34 34
Price vs. Earnings (P/E)
40 91 58 32
Price vs. Book (P/B)
81 97 88 84
Dividend Yield
1 1 1 1
Value
47 76 53 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
94 90 82 88
Profit Growth
12 77 45 4
Capital Growth
96 1 21 98
Stock Returns
29 1 15 7
Growth
69 32 29 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
52 56 58 100
Refinancing
89 87 93 88
Liquidity
8 8 12 17
Safety Safety
65 65 65 58

Similar Stocks

Discover high‑ranked alternatives to DarioHealth and broaden your portfolio horizons.

BMW

XTRA:BMW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Repsol

BME:REP
Country: Spain
Industry: Oil & Gas Integrated
Size: X-Large
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Prosus

ENXTAM:PRX
Country: Netherlands
Industry: Internet Retail
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: